Menu
Recruiting NCT05113043

Correlation Between Intestinal Microecology Imbalance and Stroke in Young Adults

Observational Ischemic Stroke Hemorrhagic Stroke

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Ischemic Stroke, Hemorrhagic Stroke. Basic parameters: 18 years — 45 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Research on Correlation Between Intestinal Microecology Imbalance and the Risk and Prognosis of Stroke in Young Adults

Overview

The relationship between the intestinal microecology and stroke has become a research hotspot in neurology field today. Maintaining the balance of the intestinal microbiota are expected to bring new breakthroughs for prevention and treatment of stroke. In recent years, stroke in young adults has an increasing incidence and a considerable socioeconomic impact because of high disability rate and health-care costs. So there is an urgent need to explore the role and mechanism of intestinal microecology imbalance in stroke, especially in the development and prognosis of stroke in young people. This study aims to use multi-omics technologies, including microbial diversity, metagenomics and metabonomics, to reveal the characteristics of intestinal flora in young stroke patients, identify biomarkers for predicting outcome after stroke and early detection of young people at high risk of stroke, and to further explore the role of gut-brain axis in the pathogenesis of stroke.

Primary outcome measures

  • Modified Rankin Scale scores [Time frame: 3 months]

Eligibility criteria

Inclusion criteria

  • Clinical diagnosis of acute ischemic or hemorrhagic stroke
  • Admission within 12 hours
  • Aged 18-45 years

Exclusion criteria

  • History of neurological diseases, myocardial infarction, renal and hepatic abnormalities and metabolic diseases
  • Combined with tumors, inflammatory bowel disease and other digestive system diseases
  • Combined with serious life-threatening diseases or condition
  • Any antibiotics, probiotics or prebiotic treatment within 3 months
  • Deteriorate and die before collecting faecal samples

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-control

Study locations

China · 2 centers
  • Shanghai 6th People's Hospital — Shanghai
  • Shanghai 6th People's Hospital — Shanghai

Identifiers

NCT: NCT05113043 · 2021-KY-112 (K)

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗